Ayala Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ayala Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2022.
  • Ayala Pharmaceuticals, Inc. Debt-to-equity for the quarter ending October 31, 2022 was 12.1 %, a 34.7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 12.1 -6.43 -34.7% Oct 31, 2022
Q2 2022 13.8 -6.09 -30.7% Jul 31, 2022
Q1 2022 14.6 -8.24 -36.1% Apr 30, 2022
Q4 2021 16.1 -9.9 -38% Jan 31, 2022
Q3 2021 18.6 -7.75 -29.5% Oct 31, 2021
Q2 2021 19.9 -3.02 -13.2% Jul 31, 2021
Q1 2021 22.8 +3.42 +17.6% Apr 30, 2021
Q4 2020 26 +9.32 +55.8% Jan 31, 2021
Q3 2020 26.3 +7.43 +39.4% Oct 31, 2020
Q2 2020 22.9 -19 -45.4% Jul 31, 2020
Q1 2020 19.4 -42.4 -68.6% Apr 30, 2020
Q4 2019 16.7 -63.4 -79.2% Jan 31, 2020
Q3 2019 18.9 -78.1 -80.5% Oct 31, 2019
Q2 2019 41.9 -38.8 -48.1% Jul 31, 2019
Q1 2019 61.8 -7.38 -10.7% Apr 30, 2019
Q4 2018 80.1 +18.6 +30.2% Jan 31, 2019
Q3 2018 97 +46.2 +90.9% Oct 31, 2018
Q2 2018 80.7 +35.6 +79.1% Jul 31, 2018
Q1 2018 69.2 +32.4 +87.8% Apr 30, 2018
Q4 2017 61.6 +34.1 +124% Jan 31, 2018
Q3 2017 50.8 +32.5 +177% Oct 31, 2017
Q2 2017 45 +38 +536% Jul 31, 2017
Q1 2017 36.9 +30.7 +499% Apr 30, 2017
Q4 2016 27.5 +21.8 +386% Jan 31, 2017
Q3 2016 18.4 +12.8 +230% Oct 31, 2016
Q2 2016 7.08 -0.52 -6.83% Jul 31, 2016
Q1 2016 6.16 -4.48 -42.1% Apr 30, 2016
Q4 2015 5.65 -6.12 -52% Jan 31, 2016
Q3 2015 5.56 -9.53 -63.1% Oct 31, 2015
Q2 2015 7.61 -11.4 -59.9% Jul 31, 2015
Q1 2015 10.6 -34.3 -76.4% Apr 30, 2015
Q4 2014 11.8 -148 -92.6% Jan 31, 2015
Q3 2014 15.1 +1.38K Oct 31, 2014
Q2 2014 19 +181 Jul 31, 2014
Q1 2014 45 +210 Apr 30, 2014
Q4 2013 159 +310 Jan 31, 2014
Q3 2013 -1.36K -1.21K -813% Oct 31, 2013
Q2 2013 -162 -16.8 -11.6% Jul 31, 2013
Q1 2013 -165 -25.5 -18.3% Apr 30, 2013
Q4 2012 -151 Jan 31, 2013
Q3 2012 -149 Oct 31, 2012
Q2 2012 -145 Jul 31, 2012
Q1 2012 -139 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.